Emad Abu-Assi Selected Research

Myocardial Infarction

4/2024	Is pre-diabetes a predictor of events in patients with atrial fibrillation?
9/2023	Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction.
11/2022	Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study.
4/2022	Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
8/2021	Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry.
1/2021	Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke.
11/2020	The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study.
6/2020	Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries.
1/2020	Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
10/2019	Renin-Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emad Abu-Assi Research Topics

Disease

37	Acute Coronary Syndrome 01/2023 - 01/2012
35	Hemorrhage 04/2024 - 01/2012
23	Myocardial Infarction 04/2024 - 01/2012
10	Atrial Fibrillation 05/2024 - 10/2014
8	ST Elevation Myocardial Infarction 07/2023 - 06/2010
8	Heart Failure 01/2023 - 07/2017
8	Thrombosis (Thrombus) 08/2021 - 01/2018
6	Neoplasms (Cancer) 05/2023 - 02/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 01/2012
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 11/2016
5	Frailty 01/2019 - 04/2016
4	Infarction (Infarctions) 08/2021 - 03/2016
4	Stroke (Strokes) 01/2021 - 12/2018
4	Non-ST Elevated Myocardial Infarction 08/2019 - 06/2010
3	Diabetes Mellitus 09/2023 - 09/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2017
2	Body Weight (Weight, Body) 12/2022 - 11/2013
2	Chronic Renal Insufficiency 01/2022 - 12/2018
2	Anemia 01/2022 - 01/2018
2	Peripheral Arterial Disease 01/2022 - 01/2018
2	Atherosclerosis 01/2021 - 11/2017
2	Ischemia 01/2020 - 09/2016
1	Hypotension (Low Blood Pressure) 01/2023
1	Pericarditis 01/2023
1	Ventricular Remodeling 01/2023
1	Takotsubo Cardiomyopathy 01/2023
1	Overweight 12/2022
1	Embolism (Embolus) 12/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hypertriglyceridemia 01/2021
1	Heart Diseases (Heart Disease) 06/2020
1	Transient Ischemic Attack 01/2020
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2019
1	Delirium 02/2019
1	Cross Infection (Nosocomial Infection) 02/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Disease Progression 06/2017
1	Dementia (Dementias) 06/2017
1	Pathologic Constriction (Stenosis) 07/2016
1	Starvation 01/2016
1	Ventricular Fibrillation 10/2015

Drug/Important Bio-Agent (IBA)

19	TicagrelorIBA 11/2022 - 03/2016
15	Prasugrel Hydrochloride FDA Link 11/2022 - 01/2018
14	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2023 - 01/2018
10	Clopidogrel (Plavix)FDA Link 11/2022 - 03/2016
9	omega-Chloroacetophenone (Mace)IBA 04/2022 - 02/2017
6	CreatinineIBA 04/2019 - 10/2013
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 12/2016
5	Angiotensin Receptor AntagonistsIBA 10/2021 - 12/2016
4	AnticoagulantsIBA 04/2024 - 01/2020
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 08/2019
4	Vitamin K FDA Link 01/2020 - 10/2014
3	DiureticsIBA 12/2023 - 02/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2019 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2017
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2018
2	Proton Pump InhibitorsIBA 09/2016 - 03/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	SteroidsIBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2023
1	SymportersIBA 01/2022
1	SodiumIBA 01/2022
1	Digoxin (Digitek)FDA LinkGeneric 10/2021
1	Fluorine-18IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Cocaine (Cocaine HCl)IBA 11/2017
1	Heroin (Diamorphine)IBA 11/2017
1	Illicit Drugs (Recreational Drugs)IBA 11/2017
1	AmphetaminesIBA 11/2017
1	Protective AgentsIBA 02/2017
1	pro-brain natriuretic peptide (1-76)IBA 11/2016
1	bafilomycin A1IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016

Therapy/Procedure

37	Therapeutics 09/2023 - 04/2014
26	Percutaneous Coronary Intervention 01/2023 - 07/2013
8	Stents 08/2021 - 01/2018
4	Transcatheter Aortic Valve Replacement 01/2023 - 07/2016
3	Secondary Prevention 01/2023 - 11/2020
3	Blood Transfusion (Blood Transfusions) 01/2018 - 10/2016
2	Conservative Treatment 11/2018 - 06/2017
2	Polypharmacy 05/2016 - 04/2016
1	Radiotherapy 05/2023
1	Contraindications 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Patient Readmission 01/2022
1	Length of Stay 06/2020